Abstract
BACKGROUND: Chemotherapy-induced febrile neutropenia is a medical emergency complicating the treatment of many cancer patients. It is associated with considerable morbidity and mortality, as well as impacting on healthcare resources.
METHODS: A prospective study of all cases of chemotherapy-induced febrile neutropenia in the South West London Cancer Network was conducted over a 4-month period. Factors including demographics, treatment history, management of febrile neutropenia and outcome were recorded.
RESULTS AND CONCLUSION: Our results reflect those of the recent National Chemotherapy Advisory Group (NCEPOD, 2008)/National Confidential Enquiry into Patient Outcomes and Death reports (NCAG, 2009) and highlight the need for network-wide c inical care pathways to improve outcomes in this area.
Original language | English |
---|---|
Pages (from-to) | 407-412 |
Number of pages | 6 |
Journal | BJC: British Journal of Cancer |
Volume | 104 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Feb 2011 |
Keywords
- neutropenic sepsis
- chemotherapy
- infection
- febrile neutropenia
- COLONY-STIMULATING FACTORS
- NON-HODGKINS-LYMPHOMA
- RANDOMIZED CONTROLLED-TRIAL
- ANTIBACTERIAL PROPHYLAXIS
- ELDERLY-PATIENTS
- DOSE-INTENSITY
- SOLID TUMORS
- MORTALITY
- METAANALYSIS
- GUIDELINES